|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: The reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial 显示文摘 | Raal F Scott R Somaratne R | 2012 | Circulation2012，126，20： | 1 |
| 2 | Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145) : a pooled analysis of more than 1,300 patients in 4 phase II trials显示文摘 | Raal FJ Giugliano RP Sabatine MS | 2014 | J Am Coil Cardiol2014，63，13： | 1 |
| 3 | Mapping and conservation importance rating of the South African coastal vegetation as an aid to development planning显示文摘 | Burns M E R | 1996 | Landscape and Urban Planning1996，34，： | 1 |
| 4 | Leptin, adiponeetin, and high-sensitivity C-reactive protein in relation to the metabolic syndrome in urban South African blackswith and without coro- nary artery disease显示文摘 | Ntyintyane L Panz V Raal FJ | 2009 | Metab Syndr Relat Disord2009，7，3： | 1 |
| 5 | A dose-titration andcomparative study of rosuvastatin and atorvastatin in patientswith homozygous familial hypercholesterolaemia显示文摘 | Marais AD Raal FJ Stein EA | 2008 | Athero-sclerosis2008，，： | 1 |
| 6 | Low- density lipoprotein cholesterol- lowering effects of AMG 145, a monoclonal antibody to proprotein eonvertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the reduction of LDL-C with PCSK9 inhi - bition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) randomized trial显示文摘 | RAAL F SCOTT R SOMARATNE R | 2012 | Circulation2012，126，20： | 1 |
| 7 | Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1显示文摘 | Panz V R Bonegio R Raal F J | 2002 | Transplantation2002，73，4： | 1 |
| 8 | Performance of the Cardio- Chek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids 显示文摘 | Panz VR Raal FJ Paiker J | 2005 | Cardiovasc J S Afr2005，16，2： | 1 |
| 9 | Leptin, adiponectin, and high- sensitivity C-reactive protein in relation to the metabolic syndrome in urban South Mrican blacks with and without coronary artery disease 显示文摘 | Ntyintyane L Panz V Raal FJ | 2009 | Metab Syndr Relat Disord2009，7，3： | 1 |
| 10 | Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisinlkexin type 9 serine protease in patients witb heterozygous familial hypercbolesterolernia , the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial显示文摘 | RAAL F SCOTT R SOMARATNE R et at | 2012 | Circulation2012，126，20： | 1 |
| 11 | PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia :results of a randomised, double-blind, placebo-controlled trial 显示文摘 | Raal FJ Stein EA Dufour R | 2015 | Lancet2015，385，1： | 1 |
| 12 | Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial显示文摘 | KOREN MJ GIUGLIANO R P RAAL FJ | 2014 | Circulation2014，129，2： | 1 |
| 13 | Reactivity of the cement-bentonite interface with alkaline solutions using transport cells 显示文摘 | Raal Femandez Jaime Cuevas Laura Sa'nchez Raquel Vigil de la Villa Santiago Leguey | 2006 | Applied Geochemistry2006，21，： | 1 |
| 14 | Diabetogenic efect of tacrolimus in South African patients undergoing kidney transplantation 显示文摘 | Panz VR Bonegio R Raal F J | 2002 | Transplantation2002，73，4： | 1 |
| 15 | Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1显示文摘 | Panz VR Bonegio R Raal FJ | | 0，，04： | 1 |
| 16 | Analysis of fac- tors associated with variability in haemodialysis ade quaey显示文摘 | Lambie SH raal MW Fluck RJ | 2004 | Nephrol Dial Transplant2004，19，2： | 1 |
| 17 | Low-density lipoprotein cholesterol-lower- ing effects of AMG 145, a monoclonal antibody to proprotein convertase subtili- sin/kexin type 9 sefine protease in patients with heterozygous familial hyperchol- esterolemia: the reduction of LDL-C with PCSK9 inhibition in hetemzygous fa- milial hypercholesterolemia disorder ( RUTHERFORD ) randomized trial 显示文摘 | Raal F Scott R Somaratne R | 2012 | Circulation2012，126，： | 1 |
| 18 | Atherosclerosis seems not to be associated with hyperinsulinaemia in patients with familial hypercholesterolaemia显示文摘 | Raal FJ Panz VR Pilcher GJ | 1999 | Intern Med1999，246，1： | 1 |
| 19 | The evaluation of low-density lipoprotein cholesterol goals achieved on patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy:the South African Not At Goal study( SANAG) 显示文摘 | Ramjeeth A Butkow N Raal FJ | 2008 | Cardiovasc J Afr2008，19，2： | 1 |
| 20 | Targeting LDL: is lower better and is it safe?显示文摘 | Stein EA Raal FJ | 2014 | Best Pract Res Clin Endocrinol Metab2014，28，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员